Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database

Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices... 1INTRODUCTIONHospital readmissions are a significant source of patient morbidity and put a significant drain on health care resources. Studies have shown that readmissions not only expose the patients to nosocomial infections but also are a considerable source of mental stress. Readmissions significantly amplify the cost of health care in the United States, with Medicare sustaining the largest portion of cost (∼58%), followed by private insurances (∼20%) and Medicaid (∼18%). To reduce the financial burden of these readmissions, the Affordable Care Act (ACA) launched the Hospital Readmission Reduction Program (HRRP), providing financial incentives to health care institutions with low 30‐day readmission rates for certain medical conditions and penalizing those with excess readmissions.Cardiovascular implantable electronic devices (CIEDs) are an established therapy for treatment of patients with lethal ventricular arrhythmias, symptomatic brady‐arrhythmias, and for those with advanced congestive heart failure (CHF). The use of these devices has increased substantially in the last two decades, and their use is expected to increase even more in coming years due to evolving guidelines for device‐based therapy for cardiac rhythm abnormalities in the aging U.S. population.Because of its magnitude and impact on the overall cost of health care, there is a need to assess the national http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cardiovascular Electrophysiology Wiley

Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database

Loading next page...
 
/lp/wiley/causes-and-predictors-of-30-day-readmission-after-cardiovascular-hWbLjd1LMb
Publisher
Wiley
Copyright
Journal compilation © 2018 Wiley Periodicals, Inc.
ISSN
1045-3873
eISSN
1540-8167
D.O.I.
10.1111/jce.13396
Publisher site
See Article on Publisher Site

Abstract

1INTRODUCTIONHospital readmissions are a significant source of patient morbidity and put a significant drain on health care resources. Studies have shown that readmissions not only expose the patients to nosocomial infections but also are a considerable source of mental stress. Readmissions significantly amplify the cost of health care in the United States, with Medicare sustaining the largest portion of cost (∼58%), followed by private insurances (∼20%) and Medicaid (∼18%). To reduce the financial burden of these readmissions, the Affordable Care Act (ACA) launched the Hospital Readmission Reduction Program (HRRP), providing financial incentives to health care institutions with low 30‐day readmission rates for certain medical conditions and penalizing those with excess readmissions.Cardiovascular implantable electronic devices (CIEDs) are an established therapy for treatment of patients with lethal ventricular arrhythmias, symptomatic brady‐arrhythmias, and for those with advanced congestive heart failure (CHF). The use of these devices has increased substantially in the last two decades, and their use is expected to increase even more in coming years due to evolving guidelines for device‐based therapy for cardiac rhythm abnormalities in the aging U.S. population.Because of its magnitude and impact on the overall cost of health care, there is a need to assess the national

Journal

Journal of Cardiovascular ElectrophysiologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off